Diagnostix uses a licensed patented protein analyzer combined with its patented software in order to outline an accelerated possible diagnosis. By using rapid blood test results on top of patients preliminary work-up such as clinical history, symptomatology and physical examination. By using artificial intelligence and machine learning, our algorithm combines millions of Epidemiological databases around the world to help reach the most specific and sensitive diagnosis regarding each particular clinical case. The more our algorithm is used, the higher its efficiency gets.
DiagnostiX uses A.I. and Machine Learning in order to reach the most specific and sensitive diagnosis. We use more than just the standard information a doctor enters when stipulating a diagnosis, as we also consider Demographic, Epidemiological data and statistics of diseases. Using Artificial Intelligence with machine learning in order to create a subset of systems to assist doctors with diagnosing patients. Creating one unified system through which global diagnostics can be conducted; irregardless of economic background.
Total Funding: $3,300,000
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2019
For AI Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI Startup founders or founders at DX Medical Solutions
DX Medical Solutions - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups DX Medical Solutions - Manage Profile